[PLX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
29-Oct-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -6.92%
YoY- -24.63%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 6,427 11,320 19,495 10,790 10,967 21,646 17,759 -49.24%
PBT -11,241 -5,475 397 -4,437 -4,150 1,667 291 -
Tax 128 2,207 -212 118 38 203 180 -20.34%
NP -11,241 -5,475 397 -4,437 -4,150 1,667 291 -
Tax Rate - - 53.40% - - -12.18% -61.86% -
Total Cost 17,668 16,795 19,098 15,227 15,117 19,979 17,468 0.76%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -174.90 -48.37 2.04 -41.12 -37.84 7.70 1.64 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.25 -0.14 0.01 -0.14 -0.13 0.10 0.02 -
EPS Diluted -0.25 -0.14 0.01 -0.14 -0.13 0.10 0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.